๐๐ธ Stark difference between big pharma over COVID
๐ AstraZeneca & Johnson&Johnson will produce their vaccines not for profit during pandemic
๐ต Pfizer now expects $15 BILLION in revenue for its vaccine THIS YEAR
๐ต with profit margin in the high 20s % -could be $4bn profit
๐บ๐ธ ๐ฉ๐ช Pfizer splits costs and profits with BioNTech
๐ Itโs vaccine costs about $20
๐ท AstraZeneca/Oxford vaccine is more like $4
๐ that vaccine will be provided to the developing world at cost in perpetuity
๐คทโโ๏ธ You pays your money & you takes your choice-Pfizer vaccine uses new, cutting edge technology & they were first to get approval
Itโs a private company with shareholders & its job is to make money - thatโs how they fund incredibly expensive research & development
๐ค But is a profit margin like that sustainable year after year if this pandemic persists and we need ongoing vaccination of populations?
Especially with a new administration in the White House, that will face huge pressure
๐ท๐บ Some info on Russian Sputnik V jab
๐ต About $10 a dose (2 dose course)
๐ 91.8% effective, inc. older groups
๐ฐ Data now peer reviewed in Lancet
๐ฅถ Store in normal 2-8c refrigeration
๐ Vaccinations starting this week in
๐ง๐ด ๐ฐ๐ฟ ๐น๐ฒ ๐ต๐ธ ๐ฆ๐ช ๐ต๐พ ๐ญ๐บ ๐ฆ๐ฒ ๐ฉ๐ฟ ๐ป๐ช ๐ฎ๐ท
โข โข โข
Missing some Tweet in this thread? You can try to
force a refresh
๐ NEW: One dose of AstraZeneca/Oxford vaccine offers 76% protection after day 22 post vaccination - and offers sustained protection through a 3 month period until second dose
New analysis by Oxford University
โถ๏ธ vaccine shows sustained protection of 76% during the 3-month interval until the second dose
โถ๏ธ analyses shows single standard dose efficacy from day 22 to day 90 post vaccination of 76% with protection not falling in this three-month period
โถ๏ธ After the second dose vaccine efficacy from two standard doses is 82.4% with the 3-month interval being used in the UK
โถ๏ธ 82.4% effective, with a 95% confidence interval of 62.7% - 91.7% at 12+ weeks